Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Maternal Autoantibodies on offspring neurodevelopment and risk for Autism Spectrum Disorder
EF 2021-22
Résumé
According to the public health agency of Canada, the current prevalence rate of ASD is 1 in 66 children and youth at a 4:1 male to female ratio. Prenatal exposure to maternal antibodies has been shown to contribute to autism in various ways depending on the antibodies involved. While the exact mechanisms have yet to be elucidated, these autoantibodies found in some women attacks the fetus brain and alter its development. Abnormal brain development is commonly implicated in children with ASD and may play a significant role in mediating the hallmark behaviours of ASD. Clinical MRI data showed children who came from mothers with autoantibodies had significantly larger brains compared to typically developing children and ASD children who were not exposed to autoantibodies.
In this study, I propose to conduct a longitudinal imaging and behaviour analysis of male and female mice prenatally exposed to a cocktail of peptides that are targets of the autoantibodies present in women who have children with ASD. Several neurodevelopmental processes occur at distinct stages of prenatal and early postnatal period in humans and rodents. Therefore, predispositions to certain stimuli, insults, or processes such as gestational exposure to autoantibodies can shift the likelihood of ASD. Longitudinal studies such as this one can help improve our understanding of the mechanisms underlying neuroanatomical differences and sex effects observed in a subset of children with ASD, as well as the developmental time course through which they manifest. The hope is that maternal autoantibodies will be able to serve as a biomarker for ASD and can help with early diagnosis and treatment interventions to enhance the childs normal development and improve their quality of life.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466862
Name
Chien Tiffany
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Maternal Autoantibodies on offspring neurodevelopment and risk for Autism Spectrum Disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibody; Autism; Behaviour; Brain; Developmental; Imaging; Immunology; Mri; Pregnancy; Prenatal
Abstract
According to the public health agency of Canada, the current prevalence rate of ASD is 1 in 66 children and youth at a 4:1 male to female ratio. Prenatal exposure to maternal antibodies has been shown to contribute to autism in various ways depending on the antibodies involved. While the exact mechanisms have yet to be elucidated, these autoantibodies found in some women attacks the fetus brain and alter its development. Abnormal brain development is commonly implicated in children with ASD and may play a significant role in mediating the hallmark behaviours of ASD. Clinical MRI data showed children who came from mothers with autoantibodies had significantly larger brains compared to typically developing children and ASD children who were not exposed to autoantibodies.
In this study, I propose to conduct a longitudinal imaging and behaviour analysis of male and female mice prenatally exposed to a cocktail of peptides that are targets of the autoantibodies present in women who have children with ASD. Several neurodevelopmental processes occur at distinct stages of prenatal and early postnatal period in humans and rodents. Therefore, predispositions to certain stimuli, insults, or processes such as gestational exposure to autoantibodies can shift the likelihood of ASD. Longitudinal studies such as this one can help improve our understanding of the mechanisms underlying neuroanatomical differences and sex effects observed in a subset of children with ASD, as well as the developmental time course through which they manifest. The hope is that maternal autoantibodies will be able to serve as a biomarker for ASD and can help with early diagnosis and treatment interventions to enhance the childs normal development and improve their quality of life.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chien, Tiffany
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~